Publications by authors named "Laly P"

This paper deals with fault detection and isolation (FDI) in complex embedded wired communication networks. The considered faults are soft faults which do not prevent the communication, but may evolve into hard faults, i.e.

View Article and Find Full Text PDF

Massive multiple-input multiple-output (mMIMO) communication systems are a pillar technology for 5G. However, the wireless radio channel models relying on the assumption of wide-sense stationary uncorrelated scattering (WSSUS) may not always be valid for dynamic scenarios. Nonetheless, an analysis of the stationarity time that validates this hypothesis for mMIMO vehicular channels as well as a clear relationship with the scattering properties is missing in the literature.

View Article and Find Full Text PDF

Sonidegib, a hedgehog pathway inhibitor, is indicated for treatment of locally advanced basal cell carcinoma, based on the results of the BOLT study. However, to date, no real-world study of sonidegib has been reported. An observational, retrospective, single-centre study (PaSoS study) was conducted.

View Article and Find Full Text PDF

We provide a unique case of haemorrhagic shock complicating a corticosteroid-resistant diffuse ulcerative enteritis in a patient treated with a combination of an anti cytotoxic T-lymphocyte antigen-4 (CTLA4) and an anti programmed cell death protein 1 (PD-1) for metastatic melanoma. Immunotherapy has changed the perspective for the management of patients with metastatic melanoma but are also responsible for digestive complications mainly represented by immunomediated colitis. Digestive bleeding is common in patients with extensive colonic lesions but has never been described in enteritis independent of colitis.

View Article and Find Full Text PDF

Introduction: Acquired haemophilia A (AHA) is a rare coagulopathy caused by the development of factor VIII antibodies. Various aetiologies have been established but a number of cases have been reported in association with autoimmune bullous dermatosis (AIBD). We report a new case of this type of association revealed by oesophageal involvement of AIBD.

View Article and Find Full Text PDF

Introduction: Keratoacanthomas (KA) are common cutaneous skin tumors originating from the hair follicles. Unlike squamous cell carcinoma, KA can regress spontaneously and have a benign evolution. Solitary KA is the most common form but familial multiple KA (Ferguson-Smith type), genetically predisposed KA (such as in xeroderma pigmentosum, or Muir-Torre syndrome), or sporadic multiple eruptive KA (Grzybowski type) have been described.

View Article and Find Full Text PDF

Immune-related adverse events (irAEs), have been reported under immune checkpoint inhibitors. Nivolumab plus ipilimumab (N + I) demonstrated meaningful improvements in key patient-reported outcomes, in patients with pretreated microsatellite instability-high (MSI-H) metastatic colorectal cancer (mCRC). We report a case of severe necrotizing myositis which occurred in a patient treated with N + I combination for mCRC MSI-H.

View Article and Find Full Text PDF
Article Synopsis
  • Targeted therapies for melanoma, specifically MEK inhibitors and BRAF/MEK combinations, have improved patient survival but may lead to adverse side effects like osteopenia.
  • Two patients with advanced melanoma developed fractures due to severe osteopenia after long-term treatment, despite having no typical risk factors for osteoporosis.
  • The study suggests that MEK inhibitors could be linked to the development of osteopenia, highlighting the need for further investigation into their long-term effects on bone health and patient quality of life.
View Article and Find Full Text PDF

Objective: To report the clinicopathologic features and outcome of myositis in patients treated with immune checkpoint inhibitors (ICIs) (irMyositis).

Methods: We retrospectively analyzed patients diagnosed with irMyositis in tertiary centers in Paris, France, and Berlin, Germany, from January 2015 to July 2017. The main outcomes were clinical manifestations and muscle histology, which included major histocompatibility complex class I (MHC-I), C5b-9, CD3, CD4, CD8, CD20, CD68, programmed cell death protein 1 (PD-1), programmed cell death 1 ligand 1 (PD-L) 1, and programmed cell death 1 ligand 2 (PD-L2).

View Article and Find Full Text PDF
Article Synopsis
  • Immune checkpoint inhibitors, like ipilimumab and nivolumab, enhance survival in advanced cancers but can lead to immune-related side effects, including hormone imbalances.
  • The article describes a patient who developed transient ACTH-dependent Cushing's syndrome after receiving these therapies, showing typical symptoms and elevated cortisol levels.
  • MRI results indicated pituitary enlargement due to ACTH secretion, followed by thyroiditis and later a serious reduction in corticotroph function, highlighting immunotherapy as a new trigger for this condition.
View Article and Find Full Text PDF
Article Synopsis
  • Advances in targeted therapy and immune checkpoint inhibitors, like cobimetinib and vemurafenib, have improved the prognosis for melanoma patients, particularly those with BRAF mutations.
  • A case study highlighted a serious side effect of cobimetinib: focal necrotizing myopathy with symptoms such as severe neck weakness and elevated creatine phosphokinase (CPK) levels, confirmed by muscle biopsy.
  • After temporarily stopping cobimetinib and normalizing CPK levels, the patient showed a partial response, leading to a continued but reduced dosage of the therapy, emphasizing the importance of being aware of potential adverse effects in future treatments.
View Article and Find Full Text PDF
Article Synopsis
  • Anti-PD-1 antibody treatment is effective for advanced melanoma, improving survival rates but comes with significant immune-related side effects like rash and thyroiditis.
  • A case study highlighted a 73-year-old man who developed autoimmune diabetes following nivolumab treatment, leading to diabetic ketoacidosis six weeks in.
  • Investigations showed pre-existing islet cell autoantibodies, indicating a potential autoimmune reaction triggered by the medication, suggesting that glucose levels should be closely monitored in patients on PD-1 blockade.
View Article and Find Full Text PDF

Introduction: A new articular syndrome described as immunrelated side effect of immunotherapy: PD-1 inhibitors have revolutionized the treatment of advanced melanoma but are responsible for immune-related toxicity. We report a case of remitting seronegative symetrical synovitis with pitting edema (RS3PE) syndrome induced by nivolumab.

Case Report: A 80 year-old man with stage IV BRAF-wild type and NRAS exon 2-mutated melanoma was treated first line by nivolumab 3mg/kg every 2 weeks.

View Article and Find Full Text PDF

Background: Granulomatous slack skin (GSS) is an extremely rare subtype of T-cell lymphoma, a variant of mycosis fungoides (MF). Herein, we describe the first reported case of GSS associated with metastatic testicular seminoma.

Patients And Methods: A 28-year-old male patient presented with circumscribed erythematous loose skin masses, especially in the body folds and which had been relapsing for 4years.

View Article and Find Full Text PDF